These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

128 related items for PubMed ID: 2547146

  • 1. Gangliosides in SV-40-transformed cells derived from Tay-Sachs disease fetal brain.
    Hoffman LM, Brooks SE, Stein MR, Adachi M, Schneck L.
    Metab Brain Dis; 1989 Jun; 4(2):87-93. PubMed ID: 2547146
    [Abstract] [Full Text] [Related]

  • 2. Tay-Sachs disease brain cells in culture: mobilization of stored GM2 after concanavalin A-mediated uptake of hexosaminidase A.
    Hoffman LM, Brooks SE, Amsterdam D, Oropello J, Schneck L.
    J Neurosci Res; 1980 Jun; 5(5):413-7. PubMed ID: 7441795
    [Abstract] [Full Text] [Related]

  • 3. Gangliosides containing glucosamine and galactosamine in transformed Tay-Sachs disease and normal human brain cell lines.
    Schneck L, Hoffman LM, Brooks SE, Amsterdam D.
    J Neurol Sci; 1980 Feb; 45(1):123-8. PubMed ID: 6244370
    [Abstract] [Full Text] [Related]

  • 4. Cytology, growth characteristics and cellular alterations following SV40-induced transformation of human foetal brain cells derived from a Gm2 gangliosidosis and control.
    Brooks SE, Amsterdam D, Hoffman LM, Adachi M, Schneck L.
    J Cell Sci; 1979 Aug; 38():211-23. PubMed ID: 230195
    [Abstract] [Full Text] [Related]

  • 5. Ganglioside loading of cultured fibroblasts: a provocative method for the diagnosis of the GM2 gangliosidoses.
    Charrow J, Binns HJ.
    Clin Chim Acta; 1986 Apr 15; 156(1):41-9. PubMed ID: 2938852
    [Abstract] [Full Text] [Related]

  • 6. GM2 ganglioside accumulation causes neuroinflammation and behavioral alterations in a mouse model of early onset Tay-Sachs disease.
    Demir SA, Timur ZK, Ateş N, Martínez LA, Seyrantepe V.
    J Neuroinflammation; 2020 Sep 20; 17(1):277. PubMed ID: 32951593
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Progranulin associates with hexosaminidase A and ameliorates GM2 ganglioside accumulation and lysosomal storage in Tay-Sachs disease.
    Chen Y, Jian J, Hettinghouse A, Zhao X, Setchell KDR, Sun Y, Liu CJ.
    J Mol Med (Berl); 2018 Dec 20; 96(12):1359-1373. PubMed ID: 30341570
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. GM2 ganglioside in fetal Tay-Sachs disease brain cultures: a model system for the disease.
    Hoffman LM, Amsterdam D, Schneck L.
    Brain Res; 1976 Jul 23; 111(1):109-17. PubMed ID: 953690
    [Abstract] [Full Text] [Related]

  • 12. Effect of modification of sialic acid on enzymic hydrolysis of gangliosides GM1 and GM2.
    Li SC, Serizawa S, Li YT, Nakamura K, Handa S.
    J Biol Chem; 1984 May 10; 259(9):5409-10. PubMed ID: 6232275
    [Abstract] [Full Text] [Related]

  • 13. Lyso-GM2 ganglioside: a possible biomarker of Tay-Sachs disease and Sandhoff disease.
    Kodama T, Togawa T, Tsukimura T, Kawashima I, Matsuoka K, Kitakaze K, Tsuji D, Itoh K, Ishida Y, Suzuki M, Suzuki T, Sakuraba H.
    PLoS One; 2011 May 10; 6(12):e29074. PubMed ID: 22205997
    [Abstract] [Full Text] [Related]

  • 14. Enzyme replacement treatment for Tay-Sachs disease brain cells in culture utilizing concanavalin A-mediated hexosaminidase A uptake: biochemical and morphological evidence of GM2 mobilization.
    Brooks SE, Hoffman LM, Adachi M, Amsterdam D, Schneck L.
    Acta Neuropathol; 1980 May 10; 50(1):9-17. PubMed ID: 7376831
    [Abstract] [Full Text] [Related]

  • 15. The protein activator specific for the enzymic hydrolysis of GM2 ganglioside in normal human brain and brains of three types of GM2 gangliosidosis.
    Hirabayashi Y, Li YT, Li SC.
    J Neurochem; 1983 Jan 10; 40(1):168-75. PubMed ID: 6848657
    [Abstract] [Full Text] [Related]

  • 16. The mutation mechanism causing juvenile-onset Tay-Sachs disease among Lebanese.
    Hechtman P, Boulay B, Bayleran J, Andermann E.
    Clin Genet; 1989 May 10; 35(5):364-75. PubMed ID: 2527097
    [Abstract] [Full Text] [Related]

  • 17. Restoration of the GM2 ganglioside metabolism in bone marrow-derived stromal cells from Tay-Sachs disease animal model.
    Martino S, Cavalieri C, Emiliani C, Dolcetta D, Cusella De Angelis MG, Chigorno V, Severini GM, Sandhoff K, Bordignon C, Sonnino S, Orlacchio A.
    Neurochem Res; 2002 Aug 10; 27(7-8):793-800. PubMed ID: 12374215
    [Abstract] [Full Text] [Related]

  • 18. The metabolism of Tay-Sachs ganglioside: catabolic studies with lysosomal enzymes from normal and Tay-Sachs brain tissue.
    Tallman JF, Johnson WG, Brady RO.
    J Clin Invest; 1972 Sep 10; 51(9):2339-45. PubMed ID: 4639018
    [Abstract] [Full Text] [Related]

  • 19. Immunohistochemical demonstration of GM2-ganglioside in the central nervous system of a 19-week-old fetus of Tay-Sachs disease.
    Taniike M, Inui K, Hirabayashi Y, Tsukamoto H, Nishimoto J, Midorikawa M, Okada S, Yabuuchi H.
    J Inherit Metab Dis; 1989 Sep 10; 12 Suppl 2():372-4. PubMed ID: 2512447
    [No Abstract] [Full Text] [Related]

  • 20. Occurrence of lysoganglioside lyso-GM2 (II3-Neu5Ac-gangliotriaosylsphingosine) in GM2 gangliosidosis brain.
    Neuenhofer S, Conzelmann E, Schwarzmann G, Egge H, Sandhoff K.
    Biol Chem Hoppe Seyler; 1986 Mar 10; 367(3):241-4. PubMed ID: 3707714
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.